Navigation Links
DSM and DecImmune Therapeutics Sign Agreement to Develop N2 Pathway Blocking Antibody
Date:4/21/2013

acturing site in Groningen, the Netherlands, DSM is starting up operations in 2013 in Brisbane, Australia, with the support of the Government of Queensland and the Commonwealth of Australia. The Brisbane facility is DSM's prototype 'biologics plant of the future' for the production of biopharmaceuticals employing DSM's proprietary technologies. DSM's technologies drive down cost, processing times, scale-up risk and capital requirements to meet market demand for developing cost-effective, lifesaving medications.

"Partnering with DSM for its antibody process development and manufacturing enables DecImmune to move rapidly through late preclinical studies and into clinical development. DSM's experience, capacity, and technical expertise in Groningen and Brisbane meet the full range of DecImmune's manufacturing needs. We look forward to working with one of the world's leading science-based companies as our manufacturing partner," stated Christopher K. Mirabelli , Ph.D., President and CEO of DecImmune and Managing Director at HealthCare Ventures, DecImmune's lead investor.

"In line with DSM's stated strategy, and fulfillment of its commitment to bring manufacturing and technological excellence to the global biopharmaceutical market, this agreement with DecImmune represents the best of what DSM is doing to help our customers serve critical needs in healthcare. The combination of the Groningen and Brisbane operations will support DecImmune throughout the development process and on to clinical trials." declared Alexander Wessels , President and CEO of DSM Pharmaceutical Products.

David Hughes , CEO of BioPharmaceuticals Australia (BPA), said "We have always been o
'/>"/>

SOURCE DSM Pharmaceutical Products
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Serina Therapeutics Announces Agreement Retaining Woodside Capital Partners as Advisor and Investment Bank
2. Serina Therapeutics Announces Worldwide Exclusive License Agreement with The Scripps Research Institute for Click Chemistry
3. Mast Therapeutics Presents MST-188 Data at 7Th Annual Sickle Cell Disease Research and Educational Symposium
4. Society for Brain Mapping and Therapeutics (SBMT) announce the formation of American Board of Brain Mapping, its 2013 award recipients and its Brain Mapping Day at the US Congress
5. Sorbent Therapeutics Initiates Phase 2b Clinical Trial of CLP-1001 for Treatment of Signs and Symptoms of Fluid Overload in Patients with Heart Failure
6. NewGen Therapeutics Presents Data on NT-113, A Novel Pan-ErbB Inhibitor, at American Association of Cancer Research
7. Sorrento Therapeutics, Inc. and IGDRASOL Announce Presentation on Non-Biologic Nanoparticle paclitaxel (NBN-Pac) Formulations for the Treatment of Solid Tumors at the Nanomedicine 2013 Meeting in Barcelona, Spain
8. Spencer Trask Congratulates InVivo Therapeutics on its Recent Approvals from the FDA
9. Zacks Industry Outlook Highlights: Eli Lilly, Novo Nordisk, Biogen, Amgen and Osiris Therapeutics
10. Adenosine Therapeutics Engages Needham & Company to Explore Strategic Options for Phase III Cardiac Stress Agent
11. Halozyme Therapeutics Names Matt Posard to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... A new survey of health care ... (CER) will yield improvements in health care decision-making, ... of CER in the current environment. The National ... shows that they view CER as important, expect ... and decision-making in the next three to five ...
(Date:3/26/2015)... 2015 Zimmer Holdings, Inc. (NYSE and SIX: ZMH) ... to serve as a feature-rich resource for patients of its ... For those experiencing knee pain, the Gel-One Patient ... knee pain and helps them understand more about the potential ... non-surgical treatment option. For those who have had a ...
(Date:3/26/2015)... ROCKVILLE, Md. , March 26, 2015  RegeneRx ... that it has received a patent acceptance notice from ... beta 4 (TB4) to prevent or reduce tissue damage ... often the case when cardiac vessels are opened after ... circumstances when treating stroke victims. Damage can ...
Breaking Medicine Technology:NPC Highlights Stakeholder Views on Comparative Effectiveness Research and the Environment for Health Care Decision-Making 2NPC Highlights Stakeholder Views on Comparative Effectiveness Research and the Environment for Health Care Decision-Making 3NPC Highlights Stakeholder Views on Comparative Effectiveness Research and the Environment for Health Care Decision-Making 4Zimmer Launches New Patient Education And Engagement Mobile App For Gel-One Hyaluronate 2RegeneRx Receives Israeli Patent Acceptance Notice for the Use of TB4 To Prevent Tissue Damage Associated with Heart Attack and Stroke Treatments 2RegeneRx Receives Israeli Patent Acceptance Notice for the Use of TB4 To Prevent Tissue Damage Associated with Heart Attack and Stroke Treatments 3
... 16 BioVex Inc, a biotechnology,company developing clinical ... that the abstract describing the interim results,from its ... advanced metastatic,melanoma is now available at the American ... http://www.asco.org . A summary of the abstract,which describes ...
... Nektar,s Technology Enables First-Ever PEGylation of a Small Molecule with ... Demonstrated Therapeutic ... NKTR ) announced initial results today from a Phase ... activity in patients with refractory solid tumors. The study,also demonstrates ...
Cached Medicine Technology:BioVex to Report Phase II Clinical Trial Results of OncoVEX GM-CSF in Metastatic Melanoma at the 2008 American Society of Clinical Oncology Meeting 2BioVex to Report Phase II Clinical Trial Results of OncoVEX GM-CSF in Metastatic Melanoma at the 2008 American Society of Clinical Oncology Meeting 3Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings 2Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings 3Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings 4Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings 5
(Date:3/26/2015)... “The SWEET Act is an important step to ... and help parents who are working to reduce sugar in ... to support public health, and we will continue to stand ... of all families,” said Dr. Jane Delgado President and CEO ... of the Sugar-Sweetened Beverage Tax (SWEET) Act by Congresswoman Rosa ...
(Date:3/26/2015)... Visiting Nurse Association of Northern ... gala fundraiser, Lighting the Way, Brightening the Day, on ... Madison Hotel in Morristown, NJ. , Guests will ... musician Rio Clemente, delightful cuisine, an extensive silent auction ... Additionally, two prestigious awards will be presented to this ...
(Date:3/26/2015)... CO (PRWEB) March 26, 2015 Saving ... help where it is most needed but least available. ... therapeutic milk to six clinics in the Benguela province ... severe malnutrition. During a recent visit to their clinics, ... to the mothers and their babies in a nation ...
(Date:3/26/2015)... Md. (PRWEB) March 26, 2015 ... than $11.3 billion in 2014, according to an ... , The Annapolis-based healthcare real estate (HRE) data ... board members and two new Gold-Level Partners: Harrison ... Investment Services. , MOB transactions still going strong, ...
(Date:3/26/2015)... 2015 Dr. Alex Rabinovich and his ... expanded offerings for Bay Area patients considering dental implants ... has long been a top-rated center, serving primarily San ... meet the strong demand by others throughout Northern California. ... top-rated dental implant facility in San Francisco,”explained Dr. Alex ...
Breaking Medicine News(10 mins):Health News:National Alliance for Hispanic Health Statement on Introduction of SWEET Act in 114th Congress 2Health News:Morristown VNA Fundraiser to Honor Distinguished Community Members 2Health News:Saving Moses Utilized Photography in an Effort to Engage Mothers and Their Babies on a Recent Visit to Angola 2Health News:Medical Real Estate Sales Topped $11.3 Billion in 2014 2Health News:Medical Real Estate Sales Topped $11.3 Billion in 2014 3Health News:Medical Real Estate Sales Topped $11.3 Billion in 2014 4Health News:Bay Area Dental Implant Specialist, Dr. Alex Rabinovich Announces Regional Educational Strategy 2Health News:Bay Area Dental Implant Specialist, Dr. Alex Rabinovich Announces Regional Educational Strategy 3
... custom chopper!, PITTSBURGH, May 7 GNC ... Sonia Adcock at the Contra Costa Bodybuilding,Fitness and ... Performing,Arts Center in Hayward, Calif., Garcia and ... Federation,of Bodybuilding (IFBB) fitness and figure competitors. The ...
... DALLAS, May 7 The American Heart ... its second of the,planned six-publication extension to the ... Association. The journals will,be published by Lippincott Williams ... James E. Udelson, M.D., acting chief of the ...
... who speak a second or third language may have ... Aviv University study has found. Knowing and speaking many ... aging. , Dr. Gitit Kav, a clinical neuro-psychologist from ... together with her colleagues Nitza Eyal, Aviva Shorek, and ...
... Health, a global,provider of products and services that improve ... board of directors has approved a 17,percent increase in ... The regular quarterly dividend is payable on July 15 ... paid a 12-cents-per-share quarterly,dividend since July 15, 2007 and ...
... This release is available in Spanish ... Diabetes Federation (IDF) BRIDGES translational research grant program ... that will offer culturally appropriate and improved diabetes ... , The community-based study, Diabetes Self-Management Program (DSME), ...
... Patients, nurses,physicians and other hospital and healthcare advocates ... May 12 to protest the nearly $300,million in healthcare ... WHAT: "Care Today, Gone Tomorrow," a Rally to Preserve ... Street, Trenton, WHEN: 12 noon, May 12, ...
Cached Medicine News:Health News:Fitness and Figure Professionals Adela Garcia and Sonia Adcock to Represent GNC at Contra Costa Championship 2Health News:American Heart Association Announces Next New Journal - Circulation: Heart Failure Set for May Premier 2Health News:American Heart Association Announces Next New Journal - Circulation: Heart Failure Set for May Premier 3Health News:Tel Aviv University finds connection between mental fitness and multi-lingualism 2Health News:Cardinal Health Increases Quarterly Dividend by 17 Percent 2Health News:International Diabetes Federation gives grant to Philippine diabetes education program 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: